Global Transforming Growth Factor Beta 1 Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

According to APO Research, The global Transforming Growth Factor Beta 1 market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Transforming Growth Factor Beta 1 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Transforming Growth Factor Beta 1 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Transforming Growth Factor Beta 1 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Transforming Growth Factor Beta 1 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Transforming Growth Factor Beta 1 include Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co and Formation Biologics Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Transforming Growth Factor Beta 1, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Transforming Growth Factor Beta 1, also provides the sales of main regions and countries. Of the upcoming market potential for Transforming Growth Factor Beta 1, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transforming Growth Factor Beta 1 sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Transforming Growth Factor Beta 1 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Transforming Growth Factor Beta 1 sales, projected growth trends, production technology, application and end-user industry.


Transforming Growth Factor Beta 1 Segment by Company

Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG

Transforming Growth Factor Beta 1 Segment by Type

Pirfenidone
Galunisertib
Others

Transforming Growth Factor Beta 1 Segment by Application

IPF
Cancer
Others

Transforming Growth Factor Beta 1 Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transforming Growth Factor Beta 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transforming Growth Factor Beta 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transforming Growth Factor Beta 1.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transforming Growth Factor Beta 1 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transforming Growth Factor Beta 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transforming Growth Factor Beta 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Transforming Growth Factor Beta 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Transforming Growth Factor Beta 1 Market Size, 2020 VS 2024 VS 2031
1.3 Global Transforming Growth Factor Beta 1 Market Size Estimates and Forecasts (2020-2031)
1.4 Global Transforming Growth Factor Beta 1 Sales Estimates and Forecasts (2020-2031)
1.5 Global Transforming Growth Factor Beta 1 Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Transforming Growth Factor Beta 1 Market Dynamics
2.1 Transforming Growth Factor Beta 1 Industry Trends
2.2 Transforming Growth Factor Beta 1 Industry Drivers
2.3 Transforming Growth Factor Beta 1 Industry Opportunities and Challenges
2.4 Transforming Growth Factor Beta 1 Industry Restraints
3 Transforming Growth Factor Beta 1 Market by Manufacturers
3.1 Global Transforming Growth Factor Beta 1 Revenue by Manufacturers (2020-2025)
3.2 Global Transforming Growth Factor Beta 1 Sales by Manufacturers (2020-2025)
3.3 Global Transforming Growth Factor Beta 1 Average Sales Price by Manufacturers (2020-2025)
3.4 Global Transforming Growth Factor Beta 1 Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Transforming Growth Factor Beta 1 Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Transforming Growth Factor Beta 1 Manufacturers, Product Type & Application
3.7 Global Transforming Growth Factor Beta 1 Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Transforming Growth Factor Beta 1 Market CR5 and HHI
3.8.2 Global Top 5 and 10 Transforming Growth Factor Beta 1 Players Market Share by Revenue in 2024
3.8.3 2024 Transforming Growth Factor Beta 1 Tier 1, Tier 2, and Tier 3
4 Transforming Growth Factor Beta 1 Market by Type
4.1 Transforming Growth Factor Beta 1 Type Introduction
4.1.1 Pirfenidone
4.1.2 Galunisertib
4.1.3 Others
4.2 Global Transforming Growth Factor Beta 1 Sales by Type
4.2.1 Global Transforming Growth Factor Beta 1 Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Transforming Growth Factor Beta 1 Sales by Type (2020-2031)
4.2.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2020-2031)
4.3 Global Transforming Growth Factor Beta 1 Revenue by Type
4.3.1 Global Transforming Growth Factor Beta 1 Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Transforming Growth Factor Beta 1 Revenue by Type (2020-2031)
4.3.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2020-2031)
5 Transforming Growth Factor Beta 1 Market by Application
5.1 Transforming Growth Factor Beta 1 Application Introduction
5.1.1 IPF
5.1.2 Cancer
5.1.3 Others
5.2 Global Transforming Growth Factor Beta 1 Sales by Application
5.2.1 Global Transforming Growth Factor Beta 1 Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Transforming Growth Factor Beta 1 Sales by Application (2020-2031)
5.2.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2020-2031)
5.3 Global Transforming Growth Factor Beta 1 Revenue by Application
5.3.1 Global Transforming Growth Factor Beta 1 Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Transforming Growth Factor Beta 1 Revenue by Application (2020-2031)
5.3.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2020-2031)
6 Global Transforming Growth Factor Beta 1 Sales by Region
6.1 Global Transforming Growth Factor Beta 1 Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Transforming Growth Factor Beta 1 Sales by Region (2020-2031)
6.2.1 Global Transforming Growth Factor Beta 1 Sales by Region (2020-2025)
6.2.2 Global Transforming Growth Factor Beta 1 Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Transforming Growth Factor Beta 1 Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Transforming Growth Factor Beta 1 Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Transforming Growth Factor Beta 1 Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Transforming Growth Factor Beta 1 Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Transforming Growth Factor Beta 1 Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Transforming Growth Factor Beta 1 Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Transforming Growth Factor Beta 1 Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Transforming Growth Factor Beta 1 Revenue by Region
7.1 Global Transforming Growth Factor Beta 1 Revenue by Region
7.1.1 Global Transforming Growth Factor Beta 1 Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Transforming Growth Factor Beta 1 Revenue by Region (2020-2025)
7.1.3 Global Transforming Growth Factor Beta 1 Revenue by Region (2026-2031)
7.1.4 Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Transforming Growth Factor Beta 1 Revenue (2020-2031)
7.2.2 North America Transforming Growth Factor Beta 1 Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Transforming Growth Factor Beta 1 Revenue (2020-2031)
7.3.2 Europe Transforming Growth Factor Beta 1 Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Transforming Growth Factor Beta 1 Revenue (2020-2031)
7.4.2 Asia-Pacific Transforming Growth Factor Beta 1 Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Transforming Growth Factor Beta 1 Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Transforming Growth Factor Beta 1 Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Roche
8.1.1 Roche Comapny Information
8.1.2 Roche Business Overview
8.1.3 Roche Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Roche Transforming Growth Factor Beta 1 Product Portfolio
8.1.5 Roche Recent Developments
8.2 Shionogi Ltd
8.2.1 Shionogi Ltd Comapny Information
8.2.2 Shionogi Ltd Business Overview
8.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Shionogi Ltd Transforming Growth Factor Beta 1 Product Portfolio
8.2.5 Shionogi Ltd Recent Developments
8.3 Acceleron Pharma Inc
8.3.1 Acceleron Pharma Inc Comapny Information
8.3.2 Acceleron Pharma Inc Business Overview
8.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Portfolio
8.3.5 Acceleron Pharma Inc Recent Developments
8.4 Genzyme Corp
8.4.1 Genzyme Corp Comapny Information
8.4.2 Genzyme Corp Business Overview
8.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Genzyme Corp Transforming Growth Factor Beta 1 Product Portfolio
8.4.5 Genzyme Corp Recent Developments
8.5 Isarna Therapeutics GmbH
8.5.1 Isarna Therapeutics GmbH Comapny Information
8.5.2 Isarna Therapeutics GmbH Business Overview
8.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Portfolio
8.5.5 Isarna Therapeutics GmbH Recent Developments
8.6 Scholar Rock
8.6.1 Scholar Rock Comapny Information
8.6.2 Scholar Rock Business Overview
8.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Scholar Rock Transforming Growth Factor Beta 1 Product Portfolio
8.6.5 Scholar Rock Recent Developments
8.7 Sirnaomics Inc
8.7.1 Sirnaomics Inc Comapny Information
8.7.2 Sirnaomics Inc Business Overview
8.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Sirnaomics Inc Transforming Growth Factor Beta 1 Product Portfolio
8.7.5 Sirnaomics Inc Recent Developments
8.8 Eli Lilly and Co
8.8.1 Eli Lilly and Co Comapny Information
8.8.2 Eli Lilly and Co Business Overview
8.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Eli Lilly and Co Transforming Growth Factor Beta 1 Product Portfolio
8.8.5 Eli Lilly and Co Recent Developments
8.9 Formation Biologics Inc
8.9.1 Formation Biologics Inc Comapny Information
8.9.2 Formation Biologics Inc Business Overview
8.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Formation Biologics Inc Transforming Growth Factor Beta 1 Product Portfolio
8.9.5 Formation Biologics Inc Recent Developments
8.10 Novartis AG
8.10.1 Novartis AG Comapny Information
8.10.2 Novartis AG Business Overview
8.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Novartis AG Transforming Growth Factor Beta 1 Product Portfolio
8.10.5 Novartis AG Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Transforming Growth Factor Beta 1 Value Chain Analysis
9.1.1 Transforming Growth Factor Beta 1 Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Transforming Growth Factor Beta 1 Production Mode & Process
9.2 Transforming Growth Factor Beta 1 Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Transforming Growth Factor Beta 1 Distributors
9.2.3 Transforming Growth Factor Beta 1 Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings